Ask a question
Presentation
Program:
10:00 Welcome address & agenda – Martin Jönsson, CEO, AlzeCure
10:02 AlzeCure Pharma: Overview, vision & update – Martin Jönsson, CEO, AlzeCure
10:10 Alzheimer’s disease, societal challenges & recent developments in the field – Professor Bengt Winblad, M.D., PhD, Karolinska Institute
10:25 Alzstatin: Background & evolution – Johan Sandin, PhD, CSO, AlzeCure
10:45 NeuroRestore: Background & data supporting disease modifying effects – Pontus Forsell, PhD, Head of Discovery & Research, AlzeCure
11:05 Panel discussion & QnA – Lead by Ludwig Sjöström, FinWire
11:25 Concluding remarks – Martin Jönsson, CEO, AlzeCure
Martin Jönsson / VD AlzeCure
Professor Bengt Winblad / M.D., PhD, Karolinska Institute
Johan Sandin, PhD, CSO, AlzeCure
Pontus Forsell, PhD, Head of Discovery & Research, AlzeCure